argenx SE

NASDAQ: ARGX
Share price (8/15/25): $653.83
Market cap (8/15/25): $39.9 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Price T Rowe Associates Inc

Artisan Partners Limited Partnership

Price T Rowe Associates Inc

News Filter

Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update

Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes

Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-Of-Concept Results in Myositis and Sjogren’s Disease

Announces Results of Annual General Meeting of Shareholders

Proxies

No filings in this category.

Other Filter

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC